Blue Rhino
Payments companies reported to CMS as associated with Blue Rhino. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Blue Rhino, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Blue Rhino
These are the largest totals companies reported as associated with Blue Rhino. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| George Cheng | San Diego, CA | Pulmonary Disease | $18,582.50 |
| David Riker | San Diego, CA | Internal Medicine | $13,152.50 |
| Rodrigo Garcia Tome | Santa Monica, CA | Pulmonary Disease | $9,327.50 |
| Colin Gillespie | Cleveland, OH | Pulmonary Disease | $6,080.59 |
| Amay Parikh | Orlando, FL | Critical Care Medicine (Internal Medicine) | $4,858.45 |
| Erik Folch | Boston, MA | Pulmonary Disease | $4,632.50 |
| Adnan Majid | Boston, MA | Pulmonary Disease | $4,632.50 |
| Nicholas Pastis | Columbus, OH | Critical Care Medicine (Internal Medicine) | $4,229.39 |
| Christopher Radchenko | Cincinnati, OH | Pulmonary Disease | $4,050.00 |
| Catherine Oberg | Torrance, CA | Pulmonary Disease | $3,825.00 |
Prescribed Blue Rhino?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.